Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease

Author: Cummings Jeffrey L.  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.30, Iss.1, 2010-01, pp. : 41-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract